Mistry, GB
Alpesh Mistry, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20140179712 | PHARMACEUTICAL FORMULATION OF N-[5-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-2H-PYRAZOL-3-YL]-4-[(3R,5S)-3,5-DIMET- HYLPIPERAZIN-1-YL]BENZAMIDE - There are provided pharmaceutical compositions comprising a compound of Formula (I) as defined herein and an amount of an alkaline effervescent agent that is sufficient to provide satisfactory in vitro dissolution; and further comprising one or more pharmaceutically acceptable ingredients; and to processes for obtaining them. | 06-26-2014 |
Anil Mistry, Bedford GB
Patent application number | Description | Published |
---|---|---|
20160132495 | CONVERSION OF DOCUMENTS OF DIFFERENT TYPES TO A UNIFORM AND AN EDITABLE OR A SEARCHABLE FORMAT - A device may obtain a set of documents, including at least two documents of different document types, for conversion to a uniform and an editable or a searchable format. The set of documents may include at least two documents of a different document type. The device may determine conversion information, associated with converting the set of documents, that includes an editable or a searchable document type to which the set of documents is to be converted. The device may determine zone information, associated with converting the set of documents, that includes information that identifies a portion of the set of documents that is to be converted. The device may generate a set of converted documents based on the conversion information and the zone information. Each document, of the set of converted documents, may be of the document type. The device may provide the set of converted documents. | 05-12-2016 |
Anita Mistry, Sheffield GB
Patent application number | Description | Published |
---|---|---|
20100273261 | METHODS FOR PRODUCING SYNTHETIC SURFACES THAT MIMIC COLLAGEN COATED SURFACES FOR CELL CULTUE - The present invention discloses methods for producing synthetic surfaces that mimic collagen coated surfaces for cell culture comprising: providing a monomer source comprising one or more organic compounds which are capable of polymerization, wherein at least one organic compound is prolinol; creating a plasma of said monomer source; and contacting at least a portion of a surface with the plasma to provide a plasma polymer coated surface. Advantageously, such methods provide an animal-free, synthetic, chemically defined surface that mimics a collagen coated surface for cell culture. Advantageously, such methods not only reduce the cost and/or issues associated with animal-derived collagen but are also amenable to large scale manufacturing. | 10-28-2010 |
20120225485 | METHODS FOR PRODUCING SYNTHETIC SURFACES THAT MIMIC COLLAGEN COATED SURFACES FOR CELL CULTURE - The present invention discloses methods for producing synthetic surfaces that mimic collagen coated surfaces for cell culture comprising: providing a monomer source comprising one or more organic compounds which are capable of polymerization, wherein at least one organic compound is prolinol; creating a plasma of said monomer source; and contacting at least a portion of a surface with the plasma to provide a plasma polymer coated surface. Advantageously, such methods provide an animal-free, synthetic, chemically defined surface that mimics a collagen coated surface for cell culture. Advantageously, such methods not only reduce the cost and/or issues associated with animal-derived collagen but are also amenable to large scale manufacturing. | 09-06-2012 |
Ashvinkumar Dhirubhai Mistry, Newhouse GB
Patent application number | Description | Published |
---|---|---|
20100113493 | (PYRROLIDIN-2-YL)PHENYL DERIVATIVES - The invention relates to (pyrrolidin-2-yl)phenyl derivatives having the general Formula I | 05-06-2010 |
20100210680 | TRICYCLIC HETEROCYCLIC DERIVATIVES - The present invention relates to a tricyclic heterocyclic derivative of Formula (I) wherein the variables are as defined in the specification. The present invention further relates to pharmaceutical compositions comprising these compounds and to their use in therapy, in particular for the treatment of serotonin-mediated disorders such as obesity, schizophrenia and cognitive dysfunction. | 08-19-2010 |
20120232122 | TRICYCLIC HETEROCYCLIC DERIVATIVES - The present invention relates to a tricyclic heterocyclic derivative according to Formula (I), wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to pharmaceutical compositions comprising said tricyclic heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of serotonin mediated disorders, such as obesity. | 09-13-2012 |
Dinesh Mistry, Bradford GB
Patent application number | Description | Published |
---|---|---|
20110201839 | MANUFACTURE OF ESTERS - The invention relates to a process in which a compound R | 08-18-2011 |
Hitankumar Gulabhai Mistry, Harrow GB
Patent application number | Description | Published |
---|---|---|
20140009405 | APPARATUS AND METHOD FOR CONVEYING INFORMATION DISPLAYED ON A TOUCH SCREEN DEVICE - An apparatus and method for conveying information displayed on a touch screen are disclosed. For example, the apparatus includes an overlay having an array of pockets, a plurality of valves, wherein each pocket of the array of pockets is coupled to at least one of the plurality of valves via a respective channel, a pump coupled to the plurality of valves for providing a fluid to one or more pockets of the array of pockets and a controller in communication with the pump and each one of the plurality of valves to control an operation of the pump and each one of the plurality of valves for activating the one or more pockets of the array of pockets to correspond to information on a touch screen of the touch screen device. | 01-09-2014 |
Kanu Mistry, Warwickshire GB
Patent application number | Description | Published |
---|---|---|
20130287563 | TURBINE DIAPHRAGM CONSTRUCTION - An axial flow turbine diaphragm is constructed without welding or other metal fusion or melting techniques. Static blade units are attached to inner and outer diaphragm rings by radially inner platform portions that engage the radially inner ring, and radially outer platform portion s that engage the radially outer ring, the inner platform portions being elongate in the circumferential direction of the turbine diaphragm and the outer platform portions being elongate in a direction compatible with the stagger angle of the aerofoils. The outer circumference of the radially inner ring has a blade unit retaining feature of complementary shape and orientation to the inner platform portions of the static blade units, and the inner circumference of the radially outer ring is provided with a plurality of blade unit retaining features of complementary shape and orientation to corresponding outer platform portions of the static blade units. | 10-31-2013 |
Ketan Mistry, Middlesex GB
Kishor Kumar Mistry, Bradford GB
Patent application number | Description | Published |
---|---|---|
20120149265 | PARTICULATE COMPOSITION - A particulate composition comprising, A) an organic phase change material, B) a water insoluble polymeric matrix comprising, B1) polymeric material containing repeating monomer units formed from i) at least one hydrophobic ethylenically unsaturated monomer(s), and ii) at least one hydrophilic ethylenically unsaturated monomer(s) which provides the polymeric material with pendent functional groups, and, B2) a cross-linking component derived from a cross-linking compound which has reacted with said pendent functional groups of the polymeric material, in which the organic phase change material (A) is distributed as a separate phase throughout the water insoluble polymeric matrix (B). The invention also relates to a process of providing a particulate composition employing the steps, 1) providing an aqueous phase containing dissolved polymeric material which polymeric material contains repeating monomer units of i) at least one hydrophobic ethylenically unsaturated monomer(s), and ii) at least one hydrophilic ethylenically unsaturated monomer(s) which provides the polymeric material with pendent functional groups, 2) emulsifying the organic phase change material into the aqueous phase to form an oil in water emulsion comprising a dispersed phase of organic phase change material and a continuous aqueous phase, 3) introducing a cross-linking compound, 4) subjecting the oil in water emulsion to spray drying to evaporate water and form the particulate composition. The particulate composition can be used in a variety of thermal energy regulation or storage applications in for instance textiles, foamed articles, construction articles and electrical equipment. | 06-14-2012 |
20130302392 | HYDROGEL MICROCAPSULES - The present application provides hydrogel microcapsules, particularly, canonized hydrogel microcapsules having improved substantivity. This application further relates to the use of hydrogel microcapsules for delivering encapsulated actives in a wide range of industries and applications including: agrochemicals, pharmaceuticals, cosmetics industry, personal care products, laundering detergents, homecare & cleaning products, dish washing detergents, oral care, dental care, textiles, paper, mining, oil industry, water treatment, adhesives, coatings, plastics, sealants, construction, paints, inks and dyes onto different substrate surfaces such as skin, hair, textiles. | 11-14-2013 |
Kishor Kumar Mistry, West Yorkshire Bradford GB
Patent application number | Description | Published |
---|---|---|
20100290103 | ENCAPSULATED DISPERSIONS COMPRISING ELECTROPHORETICALLY MOBILE ORGANIC COLORANTS - The invention relates to an electrophoretic display, comprising electrodes and cells containing at least one kind of ionic, monochrome particles, a non-polar liquid and a dispersant, wherein the ionic, monochrome particles of at least one kind are essentially aggregates consisting of a carbon containing pigment and a cationic pigment orcationic pigment derivative, and the dispersantis selected from the group consisting of polyacrylates, polyesters, polyurethanes and copolymers, with the proviso that the cationic pigment or cationic pigment derivative is not a reaction product of carbonblack with diazotated procaine hydrochloride. In general, the whole quantity of the pigment and the main part, preferably at least 80%, most preferred from 95% to 100%, of the whole cationic pigment or cationic pigment derivative present within the cells is comprised in the aggregates, with essentially no pigment and only a minor part of the cationic pigment or cationic pigment derivative physically distinct from the aggregates. | 11-18-2010 |
Mayur Mistry, Bradford GB
Patent application number | Description | Published |
---|---|---|
20130193196 | CARTONS - There is provided a carton comprising a side wall (4) comprising a first panel (6) connected to a second panel (8), a first lower flap (16) hingedly connected to the first panel, the first and second panels having free ends, a second lower flap (18) hingedly connected to the second panel, a hinged locking base panel (30) hingedly connected to the first lower panel and an inner base panel (36) hingedly connected to the second lower panel, a plurality of strengthening tabs (54,56,58,60) attached to the hinged base locking panel or the inner base panel, the first lower flap being folded over and affixed to the first panel, the second lower flap being folded over and affixed to the second panel, the hinged base locking panel being folded along a hinge line (34) thereof and affixed to the inner base panel, in which substantially diagonal weakening lines (80,82,84,86) are positioned on the lower flaps. | 08-01-2013 |
Neela Sumit Mistry, Oxford GB
Patent application number | Description | Published |
---|---|---|
20090325924 | GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 12-31-2009 |
Neela Sumit Mistry, Greater London GB
Patent application number | Description | Published |
---|---|---|
20090247519 | AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain amino-ethyl-amino-aryl (AEAA) compounds which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc. | 10-01-2009 |
Nimisha Mistry, Banbury GB
Patent application number | Description | Published |
---|---|---|
20130071522 | Coffee Filter Pod - In one aspect, a coffee filter pod containing roast and ground coffee is provided wherein the roast and ground coffee has a plurimodal volume distribution density with a first peak of from 30 to 60 microns and a second peak of from 260 to 330 microns, wherein the ratio of the volume of the particles in the first peak relative to the volume of the particles in the second peak is from 2:1 to 1:2. In another aspect, a method of preparing a short coffee beverage is disclosed. A system for producing an espresso beverage and a method for producing a coffee filter pod are also provided. | 03-21-2013 |
20160073655 | METHOD OF PREPARING SHORT COFFEE BEVERAGE USING COFFEE FILTER POD - A method of preparing a short coffee beverage having a brewed volume of from 25 to 75 ml is provided. The method comprises: placing a coffee filter pod in a brewing chamber of a low pressure beverage brewing machine; passing a beverage medium through the pod to extract the roast and ground coffee; and producing a flow resistance through the coffee filter pod using a particle size distribution that leads to increased flow resistance and a pressure drop, wherein the coffee filter pod contains roast and ground coffee with a plurimodal volume distribution density with a first peak of from 30 to 60 microns and a second peak of from 260 to 330 microns, wherein the ratio of the volume of the particles in the first peak relative to the volume of the particles in the second peak is from 2:1 to 1:2. | 03-17-2016 |
Prahalad Manibhai Mistry, Manchester GB
Patent application number | Description | Published |
---|---|---|
20090041939 | Trisazo Dyes, Compositions and Ink jet Printing Processes - A compound selected from the group consisting of compounds of Formula (1) and compounds of Formula (2) or a salt thereof: | 02-12-2009 |
20090208713 | Trisazo Compounds, Compositions and Ink Jet Printing Processes - A compound selected from the group consisting of compounds of Formula (1) and compounds of Formula (2) or a salt thereof: | 08-20-2009 |
Pravin Mistry, Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20130001204 | Method and Apparatus for Surface Treatment of Materials Utilizing Multiple Combined Energy Sources - Material treatment is effected in a treatment region by at least two energy sources, such as (i) an atmospheric pressure plasma and (ii) an ultraviolet laser directed into the plasma and optionally onto the material being treated. Precursor materials may be dispensed before, and finishing material may be dispensed after treatment. Electrodes for generating the plasma may comprise two spaced-apart rollers. Nip rollers adjacent the electrode rollers define a semi-airtight cavity, and may have a metallic outer layer. | 01-03-2013 |
Rajesh Mistry, Bradford GB
Patent application number | Description | Published |
---|---|---|
20100000946 | PRODUCTION OF A FERMENTATION PRODUCT - A process of separating suspended solids from a fermentation liquor by subjecting the liquor to a solids-liquid separation stage, | 01-07-2010 |
Rohit Mistry, Watford GB
Patent application number | Description | Published |
---|---|---|
20140141419 | SINGLE TUBE QUANTITATIVE POLYMERASE CHAIN REACTION (PCR) - Provided herein are systems and methods for quantitatively monitoring target amplicons produced by polymerase chain reaction (PCR). In particular, quantitative monitoring of target amplicon(s) in a single-tube PCR reaction without separate calibration reactions are provided. | 05-22-2014 |
Shailesh Mistry, Nottingham GB
Patent application number | Description | Published |
---|---|---|
20130261178 | PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES - A compound of formula I-0, and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: | 10-03-2013 |
20140094493 | Novel Ether Linked Compounds and Improved Treatments for Cardiac and Cardiovascular Disease - A compound of Formula (I), and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: | 04-03-2014 |
20150051270 | Novel Cyclic Phenoxy Compounds and Improved Treatments for Cardiac and Cardiovascular Disease - A compound of formula I, and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: | 02-19-2015 |
Urmila Mistry, Whitley, Coventry, Warwickshire GB
Patent application number | Description | Published |
---|---|---|
20150291126 | VEHICLE ACCESS SYSTEM AND METHOD - The present invention relates to a vehicle access system ( | 10-15-2015 |
Vanisha Mistry, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20110009872 | IMPLANT DELIVERY DEVICE AND METHOD - An implant delivery device ( | 01-13-2011 |